A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IV-BP / intravenous bisphosphonate

[Related PubMed/MEDLINE]
Total Number of Papers: 12
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IV-BP  (>> Co-occurring Abbreviation)
Long Form:   intravenous bisphosphonate
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Intravenous bisphosphonate therapy in children with spinal muscular atrophy. BMD, SMA
2019 Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review. AFF, APR, BMD, GIO, LS, OI, ONJ, PAM, ZA
2015 Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States. CKD, eGFR, RI
2014 Interleukin-6 concentration changes in plasma and saliva in bisphosphonate-related osteonecrosis of the jaws. BRONJ
2014 Patients with bone metastases from solid tumors initiating treatment with a bone-targeted agent in 2011: a descriptive analysis using oncology clinic data in the US. BTAs, OSCER, RANK
2012 Assessment of zoledronic acid treatment patterns and clinical outcomes in patients with bone metastases from genitourinary cancers. BlC, GU, PC, RCC, SREs
2012 Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. ---
2012 Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan. SREs
2012 Retrospective evaluation of the clinical benefit of long-term continuous use of zoledronic acid in patients with lung cancer and bone metastases. LC, OS
10  2010 Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy. ONJ
11  2010 Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results. ---
12  2008 Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. ONJ